Alexandre Reuben, Ph.D.

We’re Hiring at MD Anderson - Alexandre Reuben, Ph.D. @AReubenPhD oncodaily.com/voices/alexand… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwtitter

This webinar features @jillfeldman4 & @LauraJBook from EGFR Resisters & Dr Alexandre Reuben @AReubenPhD from MD Anderson a 2023 EGFR Resisters/@LUNGevity grant recipient Moderated by Dr. Upal Basu Roy they discuss engineering T cells to treat lung cancer lungevity.canto.com/b/MS9BB

@MoghaddamSeyed @MDAndersonNews @MDA_UTHGrad @atstoa So well deserved, congrats Peyman!

Extremely excited to share that I am now officially a full professor with tenure! Very grateful of my lab members (past/current), collaborators, mentors, MD Anderson leadership, and of course my beloved family for all the supports. Cheers 🥂 @MDAndersonNews @MDA_UTHGrad @atstoa

Today we welcome more than 100 new students to the Graduate School. We look forward to seeing where their journeys will take them. #WeAreGSBS #orientation2024

“By working with the patient-led advocacy groups, it’s an opportunity for me to make sure that the work we are doing in the lab has a direct impact on patient outcomes.” @AReubenPhD @MDAndersonNews Learn more: brnw.ch/21wLWhE #lcsm #lungcancer #lungevityresearch

PFS of 10.3 month vs. 2.5 month in Pancreas Cancer patients with oligometastatic disease - @ACKoongMDPhD @ebludmir @ChadTangMD @MDAndersonNews @AlexSherryMD @tharakbathala @cara_haymaker @AReubenPhD @ACKoongMDPhD oncodaily.com/blog/121538/ #OncoDaily #Oncology #Cancer

🙌🧬It’s official: the first TCR gene therapy for the treatment of cancer received @US_FDA approval this evening. A milestone event for the oncology community and the 2nd cell therapy approved for solid cancers! @Adaptimmune #Tcellpower adaptimmune.com/investors-and-…

@MoghaddamSeyed @ImmunologyGSBS @MDA_UTHGrad You were an excellent director - we have big shoes to fill! Thanks so much for all of your continued support and encouragement. We are honored to have been nominated and are very much looking forward to it.

It was an honor to serve as the director of the GSBS Immunology Graduate Program during the past three years. I am extremely proud of what we accomplished, and wish the best for our new co-directors, Drs. Ekmekcioglu and Reuben. Cheers 🥂 @ImmunologyGSBS @MDA_UTHGrad @AReubenPhD

#ASCO24 Non-smoking Lung Cancer Ranked 5Th in Global Cancer Deaths in the world

We’re hiring - please reach out if you’d like to join us at @MDAndersonNews on our quest to develop new immunotherapies/cell therapies for the treatment of lung cancer. jobs.mdanderson.org/search/jobdeta…

Hakeem Lab is hiring a Visiting Fellow! Come join our team @PATRU_Emory @EmoryVaccineCtr @EmoryUniversity! At least 2 years of lab experience in Immunology or a related field. MSc preferred but not a must.

Chad, Sarah, Brittany& Linda are all never-smokers with RET-positive #lungcancer. They are parents, siblings, friends & spouses. This is their story. #lcsm @StephenVLiu @NarjustFlorezMD @VivekSubbiah youtube.com/watch?v=UJwRfb…

CCIR-Immunology Trainee Seminar Series- TOMORROW, 04/03 at 12 pm! Imm students, Krithikaa Rajkumar Bhanu from Dr. Michael Curran's lab @drcurran and Emily Bontekoe from Dr. Alexandre Reuben’s lab @AReubenPhD will be presenting their research! Lunch will be provided.

🚨Just published: The registration enabling clinical data set for an affinity-enhanced TCR targeting the cancer-germline antigen MAGE-4. Afami cell on track to be the *first* FDA approved TCR gene therapy and first gene therapy product for a solid cancer. thelancet.com/journals/lance…

1/ Do precancers in #LynchSyndrome (LS) patients generate #neoantigens that could be targetable with #vaccines to intercept #cancer development before tumor formation? Check out our study published in @AGA_Gastro 🚨🤩 @evilarsan @FahriyeDuzagac gastrojournal.org/article/S0016-… 🧵👇

MD Anderson is home to hundreds of labs and thousands of scientists with expertise in different fields. We asked four of them – Drs. Lauren Colbert, Emil Schueler, Aria Vaishnavi and Moran Amit – to share what inspires them. bit.ly/3IyhejQ @colbertle @DrAriaV @MoranAmit1 #EndCancer

Together with our collaborators from @affinit_tx , we are excited to report at #AACR24 on a suite of #bestinclass #TCR therapies discovered in the Klebanoff Lab targeting the two most common driver mutations in human cancer: KRAS (G12D) and TP53 (R175). Come say hi! #Tcellpower

Using T cells to Tackle Drug Resistance in EGFR+ Lung Cancer- @AReubenPhD lungevity.org/blogs/using-t-…

Read our interview with @AReubenPhD as he discusses using T cells to tackle drug resistance in EGFR+ lung cancer. bit.ly/3Ijk4Js #lcsm #EGFR #lungcancer

Congratulations to our Thoracic/HN Medical Oncology teams for a great research retreat. Excited for all of the great science and what is yet to come. #EndCancer #LCSM #HNCSM @MDAndersonNews